). The age incidence differed from that of Quinn and Ochsner (1953) , who reported that most of their patients with this complaint were over the age of 60, and many had hypertension.
A remarkably high incidence of cholecystitis and/or gall stones in women has been found in this series, and this is all the more significant since every patient did not have a full investigation. The frequency of Saint's triad reported here is less than that of Foster and Knutson (1958) , who examined 713 patients by choJecystogram, a radiological series of the upper gastrointestinal tract, and a barium enema and observed an incidence of 3-4%. Boles and Jordan (1958) noted Saint's triad in 6-4% of their patients with diverticular disease of the colon, and Palmer (1955) reported an incidence of 14%. Horner (1958) made a specific examination for hiatus hernia in 292 patients with diverticular disease and found an incidence of 16 3%, whereas in 160 control cases he found only a 3% incidence.
A high incidence of inguinal and femoral herniae has been reported by De La Vega et al. (1964) , 20 5% of 196 cases of diverticular disease of the colon being affected. Again the high incidence in our series raises the question of weakness of the musculature or the connective tissue in these patients.
One of the problems which arises is the difficulty in accurately distinguishing between diverticulosis and diverticulitis. We have shown that it is impossible on radiological grounds to make an accurate distinction between them. Radiology is of primary importance in the initial diagnosis of diverticular disease, but it is often difficult or impossible to determine when inflammaton is present. Some patients may have a minor degree of inflammatory reaction which leads to an erosion and resultant haemorrhage, and yet no clinical or radiological evidence of inflammation is demonstrable. Thus in the present review " diverticulosis" patients had a higher incidence of bleeding than " diverticulitis" patients, but it may be asked whether minor inflammatory reaction was present, at least, in some of the former.
According to Spriggs and Marxer (1927) (Sneddon and Turner, 1966; Crombie and Lawson, 1967; Bowden and Rose, 1969; Cant, Lewis, and Harrison, 1969) have shown that certain of the ocular manifestations of Graves's disease respond to local application of adrenergic blocking agents. Of these a 10% solution of guanethidine has been shown to give the best results, though in this concentration treatment is accompanied by a relatively high incidence of local side-effects, notably punctate keratitis (Crombie and Lawson, 1967) . It has been suggested that a 5% solution will cause a lower incidence of side-effects with only slight reduction in efficacy. The purpose of this paper is to report a double-blind controlled study of 5% local guane- thidine in the treatment of the eye signs of Graves's disease and a long-term study of the use of 5% guanethidine drops.
Patients and Methods
Twenty-two patients (seven men and fifteen women) were studied. They remained euthyroid throughout the period of the study as assessed by clinical examination and serum proteinbound iodine estimations. Fifteen patients had previously been thyrotoxic and seven of these were receiving a maintenance dose of carbimazole throughout the study. The remaining seven were suffering from ophthalmic Graves's disease (Hall, Storey, and Farmer, 1968 
Complications
The only complications noted were in the five patients who complained of sore eyes while using guanethidine. Two of these were found to have mild conjunctival injection and were unwilling to continue with the trial beyond 9 and 15 weeks respectively. The other three showed no abnormality despite repeated examinations. No case developed punctate keratitis and no general complications were noted.
The Table summarizes 
Graves's Disease-Cartlidge et al.
rmJOUNL 647 to these figures gave P<0O001 in either eye. The short-term readings likewise showed a significant decrease compared with the control results (P<0001) in either eye. The long-term compared with the initial readings showed an average decrease in palpebral aperture of 111 mm. in the left eye and 1-94 mm. in the right. Student's t test to these figures gave P<001 in the left eye and P<0 005 in the right eye. The long-term readings likewise showed a significant decrease compared with the control results (P<0 001 in either eye).
The palpebral aperture decreased by a similar amount in each eye in both the long-term and the short-term studies (P>01 in each case). There was likewise no significant difference in the decrease in palpebral aperture in patients with either treated thyrotoxicosis or ophthalmic Graves's disease (P>0 1 in each case).
Thus topical 5 % guanethidine produced a statistically significant decrease in palpebral aperture compared with control drops, which had no such effect. This decrease was maintained with long-term use and occurred in patients with either thyrotoxicosis or ophthalmic Graves's disease.
Intraocular Pressures
There was no significant difference between initial and control readings in either eye (P>0 l in each case).
The short-term compared with the initial readings showed an average decrease in intraocular pressure of 1 90 mm. Hg in both eyes. Student's t test to these figures gave P<0-02 in the left eye and P<0-025 in the right eye. The short-term readings likewise showed a significant decrease compared with the control results (P<001 in either eye).
The long-term compared with the initial readings showed an average decrease in intraocular pressure of 2-44 mm. Hg in the left eye and 2-50 mm. Hg in the right. Student's t test to these figures gave P<0-02 in the left eye and P<0-025 in the right eye. TIhe long-term readings likewise showed a significant decrease compared with the control results: P<0 001 in the left eye and P<0Q01 in the right eye.
The intraocular pressure decreased by a similar amount in each eye in both the long-term and the short-term studies (P>0'l in each case). There was likewise no significant difference in the decrease in intraocular pressure in either diagnostic category (P>0 1 in each case).
These results indicate that a 5% guanethidine solution produces a statistically significant decrease in intraocular pressure compared with control drops, which produce no such effect. This decrease was maintained in long-term use and occurred in patients with either thyrotoxicosis or ophthalmic Graves's disease.
It is of interest that a higher proportion of cases with initial or control measurements greater than 20 mm. Hg showed a decrease in intraocular pressure with guanethidine. For example, comparing short-term with control measurements in the Table: with control measurements greater than 20 mm. Hg 88% decreased by >1 mm., and with control measurements less than 20 mm. Hg 25% decreased by >1 mm.
We have noted no improvement in ophthalmoplegia or conjunctival or periorbital oedema in any patient.
When asked at the end of the trial 11 patients stated that they wished to continue with the guanethidine eye-drops.
Discussion
The most common ocular complications of Graves's disease are related to the cosmetic appearance of the eyes or ocular pain and discomfort.
The factors involved in producing the unsightly appearance of the eyes are swelling of the eyelid, chemosis, lid retraction, and exophthalmos. Of these lid retraction is the commonest, and often improves with restoration of the euthyroid state. For this reason any study of treatment of lid retraction must be made in patients with stable thyroid status. As stated previously all of our patients remained euthyroid throughout the period of study.
Our results indicate that in a high proportion of patients with thyrotoxicosis or ophthalmic Graves's disease improvement in lid retraction of 1 mm. or greater may be anticipated with the use of 5% guanethidine eye-drops. Furthermore, this improvement appears to be maintained for some months.
We have not found improvement in exophthalmos with guanethidine, despite the claims of others-for example, Bowden and Rose (1969)-and we have also noted no change in eyelid swelling and chemosis.
Reduction of intraocular pressure with local guanethidine has been noted previously (Crombie and Lawson, 1967) . Our results confirm this, though the importance of reducing intraocular pressure in Graves's disease is not fully understood. It is of interest, however, that the intraocular pressure was raised over 22 mm. Hg in 9 out of 44 eyes.
Our results and conclusions are similar to those in many other reports (Crombie and Lawson, 1967; Bowden and Rose, 1969; Cant, Lewis, and Harrison, 1969; . Our study, however, differs in, we believe, certain important respects. Firstly, we have been careful to validate our methods of measurement by assessment in a series of normal patients, and, secondly, by the use of a double-blind crossover technique we have been able so far as possible to exclude observer bias.
On the basis of our results we recommend that careful assessment of cases should be made before local guanethidine is tried. Guanethidine has no place in the treatment of exophthalmos or ophthalmoplegia. In patients who complain of unsightly lid retraction local guanethidine is sometimes of value. Nevertheless, if eye discomfort is present in such patients examination of the eyes should be performed to exclude exposure keratitis. The presence of this contraindicates the use of guanethidine.
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